MARK PULVER: Open Payments
NPI 1205007093 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 31 payments from 8 companies in 2025. Trend: 2023 $169 · 2024 $176 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $184 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| PFIZER INC. | 3 | $48 |
| UCB, Inc. | 2 | $35 |
| Organon LLC | 3 | $33 |
| LEO Pharma Inc. | 1 | $26 |
| Botanix SB Inc | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: SKYRIZI, Bimzelx, LITFULO, Rhapsido, ADBRY, COSENTYX, SOFDRA, CIBINQO.
Industry payments across UT — which companies pay providers there.
